1-2 of 2
Keywords: Pentosidine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Residual Renal Function on Plasma Levels of Advanced Oxidation Protein Products and Pentosidine in Peritoneal Dialysis Patients

Available to Purchase
Subject Area:
Nephrology
Ryuichi Furuya, Hiromichi Kumagai, Mari Odamaki, Masaaki Takahashi, Asumi Miyaki, Akira Hishida
Journal: Nephron Clinical Practice
Nephron Clinical Practice (2009) 112 (4): c255–c261.
https://doi.org/10.1159/000224792
Published Online: 16 June 2009
... and carbonyl stress in PD patients. Methods: Plasma advanced oxidation protein products (AOPP) and pentosidine were measured in PD patients with a urine volume of ≥300 ml/day (group A, n = 17) and <300 ml/day (group B, n = 14). AOPP and pentosidine were reevaluated after 12 months of follow-up in group...
View articletitled, Impact of Residual Renal Function on Plasma Levels of Advanced Oxidation Protein Products and Pentosidine in Peritoneal Dialysis Patients
Open the PDF for Impact of Residual Renal Function on Plasma Levels of Advanced Oxidation Protein Products and Pentosidine in Peritoneal Dialysis Patients in another window
Journal Articles

Serum Levels of the Advanced Glycation End Products N ε -Carboxymethyllysine and Pentosidine Are Not Influenced by Treatment with the Angiotensin Receptor II Type 1 Blocker Irbesartan in Patients with Type 2 Diabetic Nephropathy and Hypertension

Available to Purchase
Subject Area:
Nephrology
Martin Busch, Sybille Franke, Gunter Wolf, Richard D. Rohde, Günter Stein
Journal: Nephron Clinical Practice
Nephron Clinical Practice (2008) 108 (4): c291–c297.
https://doi.org/10.1159/000127838
Published Online: 24 April 2008
... to a reduction in the serum levels of the advanced glycation end products (AGEs) pentosidine and N Ε -carboxymethyllysine (CML). Methods: One hundred and ninety-six patients of the Irbesartan in Diabetic Nephropathy Trial cohort (mean age 61 ± 6.5 years, 62 female, 134 male) with a mean estimated glomerular...
View articletitled, Serum Levels of the Advanced Glycation End Products N ε -Carboxymethyllysine and Pentosidine Are Not Influenced by Treatment with the Angiotensin Receptor II Type 1 Blocker Irbesartan in Patients with Type 2 Diabetic Nephropathy and Hypertension
Open the PDF for Serum Levels of the Advanced Glycation End Products N ε -Carboxymethyllysine and Pentosidine Are Not Influenced by Treatment with the Angiotensin Receptor II Type 1 Blocker Irbesartan in Patients with Type 2 Diabetic Nephropathy and Hypertension in another window